Alzheimer’s Research UK is the world’s largest dedicated funder of dementia research.
We are committed to supporting biomedical research that will take us closer to treatments. Not only do we fund studies through our range of Project grants for tenured researchers, but build capacity though our PhD Scholarships and Research Fellowships.
Our research portfolio
Our current total research investment is £27.65m, totalling 111 projects across 3 continents.
You can find a list of our currently funded projects. You can browse about more of our funded work in our projects pages.
The International Alzheimer’s Disease Research Portfolio is a database which allows researchers to visualise and track changes in the global Alzheimer’s disease research landscape.
Research conference
Join us for the first hybrid Alzheimer’s Research UK Conference in 2022 to hear the latest findings in dementia research.
Our research strategy
Our focus is to accelerate the ‘bench-to-bedside’ journey: our funding seeks to translate scientific findings into patient benefit as rapidly as possible.
Grant schemes
Alzheimer’s Research UK has a large number of different grant schemes through which you can apply for funding.
Measuring progress and impact
We monitor the impact and progress of the research that we fund in a number of ways.
Research opportunities
We have a wide range of funding streams that support work on prevention, diagnosis and treatments.
Network Centres
The Alzheimer’s Research UK Research Network is a unique, collaborative venture in the dementia research community.
Resources and information
Find out more about experimental resources available, research guidelines and conference opportunities throughout the world.
Our UK and global partnerships
Alzheimer’s Research UK is a partner in a number of consortia and other research initiatives, both within the UK and internationally, which aim to accelerate progress in dementia research.
Our COVID-19 response – FAQs
We have outlined some of our frequently asked questions around the ARUK Covid-19 response, and how we are continuing to provide support to our Grant-holders.
